Pawnbroker among names headed for UK stock market
Pawnbroker Ramsdens is to float on the stock market in the coming weeks along with a trio of larger healthcare and property related companies.
The Middlesborough-headquartered business, which also sells jewellery and offers a mix of other financial services, has raised £15.6m from institutions ahead of its 15 February debut on AIM.
Key elements of the growth strategy include an expansion of the branch estate at a rate of 12 new stores a year over the medium term and boosting the company’s online footprint.
Also heading to the UK stock market is healthcare and life sciences investor Arix Bioscience. It plans to raise £100m and join the Main Market on 22 February.
Backed by noted fund manager Neil Woodford, Arix’s funds will likely be used to build on the portfolio of five biotech firms it has already invested in directly.
Impact Healthcare REIT hopes to float on 7 March. It is targeting a £160m issue to fund the acquisition of a portfolio of residential care homes. It plans to offer a dividend yield of 6%.
LXI REIT plans to raise £200m to invest in commercial properties and join the stock market in late February. The company looks set to target a yield of at least 5% a year. (TS)
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell Youinvest.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.